Search research articles
Contact Us
Filters
Showing results (81-90 of 104) with videos related to
Page
of 11
Sort By:
AIDS Research and Human Retroviruses
|
October 9, 2012
Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES
Benjamin Young, Kathleen E Squires, Lisa L Ross, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 21, 2025
Pharmaceutical Practice Considerations Regarding Adoption of the Race-Free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 Equations
Ruth Tarzi, Jennifer McKenzie, Michel Reid, et al.
Antiviral Therapy
|
July 22, 2015
Low bone mineral density and risk of incident fracture in HIV-infected adults
Linda Battalora, Kate Buchacz, Carl Armon, et al.
HIV Clinical Trials
|
June 15, 2010
Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients
Kathleen E Squires, Benjamin Young, Edwin DeJesus, et al.
AIDS and Behavior
|
March 12, 2021
Correction to: Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study
Patricia de Los Rios, Chinyere Okoli, Erika Castellanos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 6, 2003
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma
Rodney J Ellis, Amy Vertocnik, Edward Kim, et al.
AIDS and Behavior
|
October 7, 2020
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study
Patricia de Los Rios, Chinyere Okoli, Erika Castellanos, et al.
Trials
|
January 25, 2022
A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial
Grant A Mackenzie, Isaac Osei, Rasheed Salaudeen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 10, 2009
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients
Edwin Dejesus, Benjamin Young, Javier O Morales-Ramirez, et al.
Sexually Transmitted Infections
|
August 1, 2020
Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries
Chinyere Okoli, Nicolas Van de Velde, Bruce Richman, et al.
Page
of 11
Search research articles
Search
Showing results (81-90 of 104) with videos related to
Sort By:
Page
of 11
AIDS Research and Human Retroviruses
|
October 9, 2012
Inflammatory biomarker changes and their correlation with Framingham cardiovascular risk and lipid changes in antiretroviral-naive HIV-infected patients treated for 144 weeks with abacavir/lamivudine/atazanavir with or without ritonavir in ARIES
Benjamin Young, Kathleen E Squires, Lisa L Ross, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation
|
September 21, 2025
Pharmaceutical Practice Considerations Regarding Adoption of the Race-Free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 Equations
Ruth Tarzi, Jennifer McKenzie, Michel Reid, et al.
Antiviral Therapy
|
July 22, 2015
Low bone mineral density and risk of incident fracture in HIV-infected adults
Linda Battalora, Kate Buchacz, Carl Armon, et al.
HIV Clinical Trials
|
June 15, 2010
Safety and efficacy of a 36-week induction regimen of abacavir/lamivudine and ritonavir-boosted atazanavir in HIV-infected patients
Kathleen E Squires, Benjamin Young, Edwin DeJesus, et al.
AIDS and Behavior
|
March 12, 2021
Correction to: Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study
Patricia de Los Rios, Chinyere Okoli, Erika Castellanos, et al.
International Journal of Radiation Oncology, Biology, Physics
|
September 6, 2003
Four-year biochemical outcome after radioimmunoguided transperineal brachytherapy for patients with prostate adenocarcinoma
Rodney J Ellis, Amy Vertocnik, Edward Kim, et al.
AIDS and Behavior
|
October 7, 2020
Physical, Emotional, and Psychosocial Challenges Associated with Daily Dosing of HIV Medications and Their Impact on Indicators of Quality of Life: Findings from the Positive Perspectives Study
Patricia de Los Rios, Chinyere Okoli, Erika Castellanos, et al.
Trials
|
January 25, 2022
A cluster-randomised, non-inferiority trial of the impact of a two-dose compared to three-dose schedule of pneumococcal conjugate vaccination in rural Gambia: the PVS trial
Grant A Mackenzie, Isaac Osei, Rasheed Salaudeen, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
April 10, 2009
Simplification of antiretroviral therapy to a single-tablet regimen consisting of efavirenz, emtricitabine, and tenofovir disoproxil fumarate versus unmodified antiretroviral therapy in virologically suppressed HIV-1-infected patients
Edwin Dejesus, Benjamin Young, Javier O Morales-Ramirez, et al.
Sexually Transmitted Infections
|
August 1, 2020
Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries
Chinyere Okoli, Nicolas Van de Velde, Bruce Richman, et al.
Page
of 11